Cleerly LABS vs Study Watch
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a detailed, AI-driven analysis of coronary CT angiography (CCTA) to precisely quantify atherosclerosis, characterize plaque, and detect stenosis. This tool is ideal for clinicians seeking comprehensive anatomical and pathological insights to personalize heart disease management, stratify patient risk, and track disease progression over time.
View Cleerly LABS →Choose Study Watch if…
Choose Verily Study Watch if your objective is continuous, non-invasive physiological data collection for clinical research purposes over extended periods. This wearable device is best suited for studies requiring long-term monitoring of metrics like ECG, heart rate, and movement to identify patterns, track responses, or detect events in a real-world setting.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Study Watch |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Cloud, On-premise | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS is a web-based software with 3D visualization and integration with PACS, RIS, and EHR, making it directly usable within existing clinical workflows for healthcare professionals. Verily Study Watch is a patient-facing wearable, and while its cloud platform is for researchers, the direct clinical workflow integration for analysis is less explicit.
Clinical Value
Cleerly LABSCleerly LABS is FDA-cleared and provides AI-powered, comprehensive analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis, directly aiding personalized heart disease management and risk assessment. Verily Study Watch, also FDA-cleared, primarily offers continuous physiological monitoring for clinical research, providing data that can inform care but not direct diagnostic interpretation for a specific disease in the same way.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent pricing per analysis, with a retail price and a discounted rate, and mentions some insurance coverage, allowing for a clear assessment of its cost-effectiveness. Verily Study Watch's pricing is not publicly available, making it impossible to evaluate its value proposition.
Enterprise Readiness
Cleerly LABSCleerly LABS is cloud-based (AWS), web-based, and explicitly integrates with PACS, RIS, and EHR via an on-site proxy, demonstrating robust readiness for existing clinical IT infrastructure. While Verily Study Watch is also cloud-based and claims HIPAA compliance and BAA, the ongoing lawsuit alleging BAA breaches, even if denied, could pose a concern for enterprise adoption.
Innovation
Cleerly LABSCleerly LABS is highly innovative in applying AI to CCTA for comprehensive coronary plaque assessment, including volume and type, and ischemia detection, which represents a significant advancement in non-invasive cardiac risk stratification. Verily Study Watch's innovation lies in its multi-sensor continuous physiological monitoring for clinical research, but Cleerly's direct AI-driven diagnostic shift in cardiology feels more immediately impactful.
Support & Docs
TieBoth companies provide general information about support. Cleerly's website mentions client support and training for users. Verily's support page details resources for Data Workbench and Site CTMS, and regulatory information for Study Watch. However, without more specific details on the depth, accessibility, and quality of documentation and support channels for both, it is difficult to definitively choose a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Study Watch |
|---|---|---|
| Name | Cleerly LABS | Study Watch |
| Primary Function/Purpose | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. |
| Company | Cleerly | Verily Life Sciences |
| Key Features | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy | Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week), Internal data storage and encryption, Cloud-based data processing with algorithms and machine learning, On-demand single-channel ECG, Irregular pulse monitor, E-ink display for minimal power consumption |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Study Watch.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Study Watch
Backers
Who funded each tool's parent company.